| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |